RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

BACKGROUND: Limited information is available on the effectiveness of the BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine, especially in the elderly, despite the fact that it is approved in more than 50 countries. METHODS: RBD-specific antibody titres, as a rapidly available and highly predictive surrog...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferenci, Tamás, Sarkadi, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785690/
https://www.ncbi.nlm.nih.gov/pubmed/35073866
http://dx.doi.org/10.1186/s12879-022-07069-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785690/
https://www.ncbi.nlm.nih.gov/pubmed/35073866
http://dx.doi.org/10.1186/s12879-022-07069-z

Ejemplares similares